Dacomitinib (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dacomitinib" in English language version.

refsWebsite

Global rank English rank

1,712^th place

1,063^rd place

low place

low place

1,684^th place

1,350^th place

719^th place

636^th place

low place

low place

low place

low place

1medpagetoday.com

9,274^th place

5,856^th place

2^nd place

2^nd place

4^th place

4^th place

1semanticscholar.org

11^th place

8^th place

68^th place

117^th place

canada.ca

health-products.canada.ca

"Vizimpro Product information". Health Canada. 25 April 2012. Retrieved 29 May 2022.

cancer.gov

"Dacomitinib". NCI Drug Dictionary. National Cancer Institute, U.S. Department of Health and Human Services.

doi.org

Shirley M (December 2018). "Dacomitinib: First Global Approval". Drugs. 78 (18): 1947–1953. doi:10.1007/s40265-018-1028-x. PMID 30506139. S2CID 54034570.

europa.eu

ema.europa.eu

"Vizimpro EPAR". European Medicines Agency (EMA). 5 June 2019. Retrieved 13 December 2019.

hres.ca

hpr-rps.hres.ca

"Summary Basis of Decision (SBD) for Verzenio". Health Canada. 23 October 2014. Retrieved 29 May 2022.

medpagetoday.com

Smith M (6 June 2017). "Dacomitinib Sets PFS Record in Phase III NSCLC Trial". MedPage Today.

medscape.com

Chustecka Z (27 January 2014). "Dacomitinib Fails in Pretreated Non-small Cell Lung Cancer". Medscape.

nih.gov

pubmed.ncbi.nlm.nih.gov

Shirley M (December 2018). "Dacomitinib: First Global Approval". Drugs. 78 (18): 1947–1953. doi:10.1007/s40265-018-1028-x. PMID 30506139. S2CID 54034570.

pfizer.com

"Pfizer Announces Top-Line Results From Two Phase 3 Trials Of Dacomitinib In Patients With Refractory Advanced Non-Small Cell Lung Cancer". Pfizer Press Release. 27 January 2014.

pmlive.com

Taylor P (28 January 2014). "Blow to Pfizer as dacomitinib fails in lung cancer trials". pmlive.com.

semanticscholar.org

api.semanticscholar.org

Shirley M (December 2018). "Dacomitinib: First Global Approval". Drugs. 78 (18): 1947–1953. doi:10.1007/s40265-018-1028-x. PMID 30506139. S2CID 54034570.